CASU, Gavino
 Distribuzione geografica
Continente #
NA - Nord America 4.498
AS - Asia 4.251
SA - Sud America 2.569
EU - Europa 1.572
AF - Africa 155
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 13.057
Nazione #
US - Stati Uniti d'America 4.306
BR - Brasile 2.278
SG - Singapore 2.136
CN - Cina 704
IT - Italia 573
VN - Vietnam 395
HK - Hong Kong 376
DE - Germania 228
FR - Francia 200
AR - Argentina 102
BD - Bangladesh 99
UA - Ucraina 85
CA - Canada 82
IN - India 79
GB - Regno Unito 78
FI - Finlandia 76
RU - Federazione Russa 71
TR - Turchia 71
IQ - Iraq 64
MX - Messico 64
EC - Ecuador 54
UZ - Uzbekistan 47
ZA - Sudafrica 47
NL - Olanda 46
AT - Austria 37
JP - Giappone 37
SE - Svezia 37
VE - Venezuela 37
CO - Colombia 31
PK - Pakistan 30
KR - Corea 27
MA - Marocco 25
PL - Polonia 25
ID - Indonesia 23
KE - Kenya 22
ES - Italia 21
CZ - Repubblica Ceca 19
JO - Giordania 18
PE - Perù 18
PY - Paraguay 18
NP - Nepal 16
CL - Cile 15
KZ - Kazakistan 15
TN - Tunisia 15
AZ - Azerbaigian 14
DZ - Algeria 13
LT - Lituania 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
SA - Arabia Saudita 10
UY - Uruguay 10
LB - Libano 9
BE - Belgio 8
DO - Repubblica Dominicana 8
JM - Giamaica 8
PH - Filippine 8
AL - Albania 7
IL - Israele 7
KG - Kirghizistan 7
MY - Malesia 7
PA - Panama 7
XK - ???statistics.table.value.countryCode.XK??? 7
CR - Costa Rica 6
CH - Svizzera 5
ET - Etiopia 5
GR - Grecia 5
HU - Ungheria 5
SN - Senegal 5
AU - Australia 4
BG - Bulgaria 4
BO - Bolivia 4
HN - Honduras 4
NI - Nicaragua 4
RO - Romania 4
RS - Serbia 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TW - Taiwan 4
AO - Angola 3
BH - Bahrain 3
CG - Congo 3
GE - Georgia 3
IR - Iran 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
OM - Oman 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
GT - Guatemala 2
IE - Irlanda 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 13.038
Città #
Dallas 1.972
Singapore 1.135
San Jose 716
Hong Kong 368
Ashburn 296
Beijing 242
São Paulo 171
Lauterbourg 148
Ho Chi Minh City 136
Shanghai 119
Santa Clara 99
Hanoi 95
Los Angeles 79
Munich 72
Chandler 67
Belo Horizonte 66
Rio de Janeiro 66
New York 64
Rome 46
Helsinki 45
Orem 45
Brasília 42
Curitiba 42
Nuremberg 42
Tashkent 41
Frankfurt am Main 38
Council Bluffs 35
Tokyo 34
Jacksonville 33
Porto Alegre 33
Milan 29
Sassari 28
Boardman 27
Johannesburg 27
Brooklyn 26
Campinas 26
Chennai 26
Romola 26
Tianjin 26
Baghdad 25
Cagliari 24
Da Nang 24
Montreal 24
Seoul 24
Princeton 22
Ribeirão Preto 22
Warsaw 21
Ann Arbor 20
Boston 20
Düsseldorf 20
Guayaquil 20
Nairobi 20
Salvador 20
Amsterdam 19
Denver 19
Vienna 19
Wilmington 19
Atlanta 18
Guarulhos 18
Istanbul 18
Toronto 18
Falkenstein 17
Quito 17
Amman 16
Dhaka 16
London 16
Santo André 16
Sorocaba 16
Stockholm 16
Uberlândia 16
Belford Roxo 15
Baku 14
Buenos Aires 14
Lima 14
Mexico City 14
Betim 13
Caracas 13
Dearborn 13
Juiz de Fora 13
Nanjing 13
San Francisco 13
Ankara 12
Brno 12
Chicago 12
Gravataí 12
Houston 12
Mauá 12
São José dos Campos 12
Turku 12
Aracaju 11
Canoas 11
Columbus 11
Florence 11
Fortaleza 11
Goiânia 11
João Pessoa 11
Manaus 11
Manchester 11
Mumbai 11
Poplar 11
Totale 7.594
Nome #
Left atrial appendage occlusion: behind the bleeding risk 222
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 174
Left Atrial Appendage Closure vs. Oral Anticoagulation: still a matter of debate 172
Albumina plasmatica come indice prognostico nei pazienti con ictus cerebrale ischemico. 158
Brain anticipatory cardiovascular responses to exercise 157
Permanent pacemaker dependency after transcatheter aortic valve implantation: Prevalence, patients’ characteristics, and main determinants 151
Aging of the Arterial System 140
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 136
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry 132
Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists 132
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 131
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry 131
Follicular spicules and multiple ulcers: cutaneous manifestations of multiple myeloma 129
Diagnosis of Brugada syndrome affects quality of life and psychological status 129
Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-Analysis of Randomized Trials 121
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: Indications, patient selection, competences, organization, and operator training 114
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 113
Integrating Pharmacological Features to Personalized Models With Statin Therapy 113
Association of chromosome 9p21 with subsequent coronary heart disease events: A GENIUS-CHD study of individual participant data 110
Spicule follicolari del volto: una manifestazione cutanea peculiare del mieloma multiplo con crioglobulinemia 110
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint 110
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 108
Cerebral amyloid angiopathy and atrial fibrillation: a dangerous combination 105
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: Indications, patient selection, staff skills, organisation, and training 104
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: A webthal study 102
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2021), 34, 1, (63-73), 10.1007/s40620-020-00774-5) 102
Long‐term gender disparities in new‐onset heart failure after acute coronary syndrome 100
Left Atrial Appendage Occlusion in Patients With Non-Valvular Atrial Fibrillation and Cerebral Amyloid Angiopathy: Insights From the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 100
Serum albumin and mortality risk in old patients with acute ischemic stroke. 100
Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study 97
Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: Results from a multicentre long-term registry 97
Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or gastrointestinal bleeding: Insights from the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 97
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 96
Clinical application of virtual reality in patients with cardiovascular disease: state of the art 96
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 96
Effect of rhTSH on Lipids 96
Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry 95
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion 95
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study 94
Abstract 110: Quality of life in Beta Thalassemia 93
A double left anterior descending coronary artery emerging from the right Valsalva sinus: A case report and a brief literature review 92
An ensemble machine learning approach for predicting heart failure risk in acute coronary syndrome patients: heartguardai 92
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 92
"A heterozygous mutation of the elastin gene ( ELN: p.val154met) fully co-segregates with classic marfan phenotype in a sardinian family: a possible novel disease-gene?" 91
Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension 90
Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome 89
Ictus cerebale ischemico e infiammazione: nuovi indici di prognosi. 89
Atrial Fibrillation in Patients Undergoing Transcatheter Mitral Valve Repair: More Than Meets the Eye? 89
Safety, efficacy, and reproducibility of cavotricuspid isthmus ablation guided by the ablation index: Acute results of the FLAI study 88
Letter to the editor 88
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension 88
Efficacy and Safety of P2Y12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials 86
Anomalous origin of right coronary artery from left sinus of valsalva 85
Intra-Cardiac versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion with a Watchman FLX Device 85
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial 85
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study 85
Allergic Myocardial Infarction: An Unusual Cause of Stent Thrombosis 84
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 84
Antegrade fenestration and re-entry for bailout treatment of iatrogenic coronary dissection 83
Correspondence 82
The experience of immersive virtual reality in patients with heart failure during cardiac rehabilitation: a qualitative study 82
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 81
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 81
Improving adherence to rehabilitation for heart failure patients through immersive virtual reality (VIRTUAL-HF): A protocol for a randomized controlled trial 81
Virtual reality and cardiac rehabilitation: a new middle-range theory to outline its mechanism of effectiveness 80
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 80
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus 80
Does the age affect the outcomes of cardiac resynchronization therapy in elderly patients? 80
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 80
Regional disparities in the management and outcomes of ST-elevation myocardial infarction: an Italian analysis focusing on time-dependent reperfusion networks and in-hospital logistics 79
Vascular assisted-tracking for challenging transradial percutaneous intervention 79
Subsequent Event Risk in Individuals With Established Coronary Heart Disease 79
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 78
When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies 77
Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island 77
Highly specialized stroke care improves the 30-day survival 77
Prevalence of the RR genotypes of the locus ACTN3-R577X in Italian Muay Thai elite fighters 76
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study 76
Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study 76
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment 75
Impact of Selection Bias on Estimation of Subsequent Event Risk 74
Spontaneous Retrograde Embolization From an Infarct-Related Artery to a Bystander Nonculprit Artery: An Unclear Pathophysiological Mechanism? 73
Safety and efficacy of a light antithrombotic regimen after left atrial appendage occlusion: Insights from the LOGIC (left atrial appendage occlusion in patients with gastrointestinal or IntraCranial bleeding) international multicenter registry 73
The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective 72
The strategic alliance between clinical and molecular science in the war against sars-cov-2, with the rapid-diagnostics test as an indispensable weapon for front line doctors 72
EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder 72
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosis 71
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study 71
Theoretical basis for a new approach of studying Emery-Dreifuss muscular dystrophy by means of thermography 70
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension 70
Effectiveness of virtual reality on pain and anxiety in patients undergoing cardiac procedures: A systematic review and meta-analysis of randomized controlled trials 70
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 70
Diuretic therapy in heart failure - Current approaches 69
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 69
Brugada phenocopy in a patient with unstable angina and three-vessel coronary artery disease 68
Novel Perspectives on Genetic Evaluation in Early-Onset Atrial Fibrillation: Clinical Implications and Future Directions 68
The Italian registry of renal denervation 68
LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry 68
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 68
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2) 68
Totale 9.483
Categoria #
all - tutte 53.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202247 9 0 2 1 0 1 1 2 5 1 5 20
2022/2023119 16 12 7 20 7 18 0 12 19 2 5 1
2023/2024493 12 2 1 2 11 4 5 187 0 17 80 172
2024/20254.896 16 91 292 132 172 200 258 856 1.786 730 211 152
2025/20267.399 322 1.662 752 1.077 808 361 1.044 193 355 479 242 104
2026/202761 61 0 0 0 0 0 0 0 0 0 0 0
Totale 13.288